BACKGROUND: The number of children on home mechanical ventilation (HMV) has increased markedly in Europe and North America but little is known about the HMV use and outcomes in children in Turkey. OBJECTIVE: To review clinical conditions and outcome of children who were discharged from the hospital on respiratory support. METHODS: Thirty-four patients assessed at the Marmara University Hospital in Istanbul who had been receiving ventilatory support at home for more than 3 months were included in the study. RESULTS: Thirty-four patients with a median age of 5.1 years were discharged home with ventilatory support. HMV was started in 2001 at our institution and the number of children treated has increased substantially since then (2001: n = 1, 2002: n = 3, 2003: n = 3, 2004: n = 2, 2005: n = 14, 2006: n = 11). Ventilatory support was started at a median age of 1.8 years and continued for 13 months. Eleven (32.4%) patients received invasive mechanical ventilation via tracheostomy and 23 (67.6%) patients received noninvasive mechanical ventilation. Sixteen children (47.1%) were on noninvasive mechanical ventilation via nasal mask while 7 (20.6%) used a face mask. Seven (20.6%) patients received ventilatory support for 24 h and 27 (79.4%) patients were supported only during sleep. Twenty-four (70.6%) children received supplemental oxygen in addition to ventilatory support. Three patients successfully came off ventilatory support; 11 patients died during follow-up. None of the patients had home nursing and there were no life-threatening complications. CONCLUSIONS: A rapidly rising trend of HMV use in chronic respiratory failure (CRF) has been observed in this study. HMV can be safely applied in selected children with CRF with close monitoring and proper follow-up in developing countries despite the lack of home nursing. 2007 S. Karger AG, Basel.
BACKGROUND: The number of children on home mechanical ventilation (HMV) has increased markedly in Europe and North America but little is known about the HMV use and outcomes in children in Turkey. OBJECTIVE: To review clinical conditions and outcome of children who were discharged from the hospital on respiratory support. METHODS: Thirty-four patients assessed at the Marmara University Hospital in Istanbul who had been receiving ventilatory support at home for more than 3 months were included in the study. RESULTS: Thirty-four patients with a median age of 5.1 years were discharged home with ventilatory support. HMV was started in 2001 at our institution and the number of children treated has increased substantially since then (2001: n = 1, 2002: n = 3, 2003: n = 3, 2004: n = 2, 2005: n = 14, 2006: n = 11). Ventilatory support was started at a median age of 1.8 years and continued for 13 months. Eleven (32.4%) patients received invasive mechanical ventilation via tracheostomy and 23 (67.6%) patients received noninvasive mechanical ventilation. Sixteen children (47.1%) were on noninvasive mechanical ventilation via nasal mask while 7 (20.6%) used a face mask. Seven (20.6%) patients received ventilatory support for 24 h and 27 (79.4%) patients were supported only during sleep. Twenty-four (70.6%) children received supplemental oxygen in addition to ventilatory support. Three patients successfully came off ventilatory support; 11 patients died during follow-up. None of the patients had home nursing and there were no life-threatening complications. CONCLUSIONS: A rapidly rising trend of HMV use in chronic respiratory failure (CRF) has been observed in this study. HMV can be safely applied in selected children with CRF with close monitoring and proper follow-up in developing countries despite the lack of home nursing. 2007 S. Karger AG, Basel.
Authors: Rafael González; Amaya Bustinza; Sarah N Fernandez; Miriam García; Silvia Rodriguez; Ma Ángeles García-Teresa; Mirella Gaboli; Silvia García; Olaia Sardón; Diego García; Antonio Salcedo; Antonio Rodríguez; Ma Carmen Luna; Arturo Hernández; Catalina González; Alberto Medina; Estela Pérez; Alicia Callejón; Juan D Toledo; Mercedes Herranz; Jesús López-Herce Journal: Eur J Pediatr Date: 2017-08-12 Impact factor: 3.183
Authors: Fleur M Paulides; Frans B Plötz; Laura P Verweij-van den Oudenrijn; Josephus P J van Gestel; Mike J Kampelmacher Journal: Intensive Care Med Date: 2012-04-05 Impact factor: 17.440
Authors: Narongkorn Saiphoklang; Apichart Kanitsap; Pitchayapa Ruchiwit; Pattarin Pirompanich; Thiti Sricharoenchai; Christopher B Cooper Journal: Lung India Date: 2019 May-Jun
Authors: Mireu Park; Haerin Jang; In Suk Sol; Soo Yeon Kim; Young Suh Kim; Yoon Hee Kim; Myung Hyun Sohn; Kyung Won Kim Journal: J Korean Med Sci Date: 2019-11-04 Impact factor: 2.153